International Practices of Registration and Use of Drugs for Gene Therapy in Clinical Practice
The introduction of innovative products obtained using genetic engineering methods into clinical practice ensures the development of such a modern biomedicine area as gene therapy for, primarily, oncological, genetic, orphan diseases and other life threatening conditions, which have no effective tre...
Saved in:
Main Authors: | E. V. Melnikova, O. V. Merkulova, A. A. Chaplenko, O. A. Rachinskaya, V. A. Merkulov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC "Publishing House OKI"
2020-05-01
|
Series: | Антибиотики и Химиотерапия |
Subjects: | |
Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/122 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomedical Cell Products or High-Tech Drugs?
by: V. A. Merkulov, et al.
Published: (2019-06-01) -
Regulation for the Translation of Gene and Cell Therapy into Medical Practice in East Asian Countries
by: E. V. Melnikova, et al.
Published: (2024-02-01) -
International Approaches to Regulation of Medicinal Products Containing Viable Human Cells
by: E. V. Melnikova, et al.
Published: (2018-09-01) -
International Practice of Storing Human Cell Lines Intended for Clinical Use
by: O. A. Rachinskaya, et al.
Published: (2018-12-01) -
Description of the System of State Registration of Medicines in the Republic of Georgia as a Development Potential of Domestic Manufacturers
by: A. V. Foteeva, et al.
Published: (2021-05-01)